CAMP4 Therapeutics Corporation
CAMP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $60 | $29 | $78 | $102 |
| - Cash | $75 | $39 | $49 | $64 |
| + Debt | $6 | $7 | $8 | $9 |
| Enterprise Value | -$8 | -$3 | $37 | $46 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -46.9% | 74.5% | 31.6% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 47.7% | 100% | 100% | 100% |
| EBITDA | -$15 | -$13 | -$13 | -$14 |
| % Margin | -1,846.9% | -841.5% | -1,477.7% | -2,088.3% |
| Net Income | -$15 | -$13 | -$12 | -$13 |
| % Margin | -1,899.2% | -840.8% | -1,449.1% | -2,036.7% |
| EPS Diluted | -0.55 | -0.62 | -0.64 | -0.68 |
| % Growth | 11.3% | 3.1% | 5.9% | – |
| Operating Cash Flow | -$11 | -$10 | -$14 | -$11 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$11 | -$10 | -$15 | -$12 |